Copyrighted Image? DMCA | The Supreme Court ruled unanimously Thursday that companies cannot patent human genes, a decision that patient advocates said would increase competition and lower the cost of screenings for cancer risk and other genetic tests. DNA is "a product of nature and not patent eligible merely because it has been isolated," the court said. In something of a compromise, it ruled that genetic material created in laboratories is eligible for patent protection. |